Initial Coverage on the Polish provider of Digital Health solutions MedApp S.A.
MedApp (MDA) develops innovative mHealth solutions. Its main product is the remote health monitoring and analytics platform Carna Life, which can be connected to wearables, body sensors and other mobile medical devices and is targeted at patients, doctors and medical facilities. Carna Life already has CE registration, which allows MedApp to sell it in Europe and many other countries. Management expect to generate revenues from H2/17E, which will depend on the number of patients, exams that are conducted and analyzed by the Carna Life system as well as integrations at medical facilities in markets including Poland, the Middle East and Kazakhstan. In 2018E, MedApp plans to introduce Carna Life in North America, Western Europe and Asia.
We are a leading, management-owned research boutique with a focus on companies from Emerging Europe. Our role is that of an intermediary between companies on the one hand and investors on the other. Our research products are directly distributed to more than 200 mutual and pension funds, family offices and independent asset managers from Central and Eastern Europe, the German-speaking region, Scandinavia, France and UK. In addition, we publish our reports on platforms such as Bloomberg, Thomson Reuters, Capital IQ and PAP, thus ensuring that they are available to institutions from around the world. By organising roadshows and conferences, we provide investors with direct access to corporate decision makers. Our team consists of professionals with long capital market experience in both Western Europe and the CEE region.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.